Miss Siqi Lyu
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis
Event: ESC Congress 2023
Topic: Hypertrophic Cardiomyopathy
Session: Contemporary management of hypertrophic cardiomyopathy
Predictive values of age shock index and age modified shock index for in-hospital mortality in patients with ST-segment elevation myocardial infarction
Event: ESC Congress 2023
Topic: ST-Elevation Myocardial Infarction (STEMI)
Session: Risk stratification in acute coronary syndromes with cardiogenic shock
Predictive performance of different bleeding risk scores in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
Event: ESC Congress 2021 - The Digital Experience
Topic: Oral Anticoagulation
Session: Atrial fibrillation e-posters
Association between plasma big endothelin-1 level and the severity of coronary artery disease in patients with non-ST segment-elevated myocardial infarction
Event: ESC Congress 2021 - The Digital Experience
Topic: Biomarkers
Session: Acute Coronary Syndromes ePosters
Incremental predictive value of adding the CHA2DS2-VASc score to the GRACE score for in-hospital mortality in patients with ST-segment elevation myocardial infarction
Event: ESC Congress 2021 - The Digital Experience
Topic: ST-Elevation Myocardial Infarction (STEMI)
Session: Acute Coronary Syndromes ePosters
Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre
Event: Heart Failure 2019
Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
Session: Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30
ESC 365 is supported by
